Experimental stem cells target devastating immune reactions
Disease control
ENROLLING_BY_INVITATION
This early-stage study is testing whether infusions of specialized fetal stem cells can safely help control severe symptoms in people with serious immune-related disorders and tissue damage. The trial will enroll about 100 patients who have run out of other treatment options. Res…
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC